Oral question asked in the House of Lords, by Lord Walton of Detchant (Crossbench). It was answered on Tuesday, 17 October 2006.
Alzheimer's Disease
- Question
- My Lords, does the Minister accept that many neurologists and psychiatrists have been disappointed, as he is aware, at NICE’s recent guidance, not least because it is a matter of extremely difficult clinical judgment to tell when early Alzheimer’s disease becomes moderately severe, when the drugs may be prescribed under the NICE guidelines, and when it is advanced, when according to the guidance the drugs may not be prescribed? It is crucial that the guidance to be produced next month should be carefully examined, because the medical profession is concerned about its effects in this situation.
- Answer
-
My Lords, the noble Lord is right that this is a complex issue. That is why NICE will produce the clinical guideline next month, following consultation with a wide range of clinicians of different opinions.
Secondary information
- Type
- Oral question
- Reference
- 685 c650
- Session
- 2005-06
- Oral question type
- Supplementary
- Chamber / Committee
- House of Lords chamber
- Subjects
- Cost effectiveness Alzheimer's disease Drugs NHS National Institute for Health and Care Excellence Donepezil
- Link
- View this Oral question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2024-11-28 21:07:32 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1175390/-question
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1175390/-question
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1175390/-question